Inken Flörkemeier

10PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCancer geneticsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 17, 2025
Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma.

Inken Flörkemeier, Hannah L Hotze, Anna Lena Heyne

|Apr 17, 2025
<i>In Vivo</i> and <i>In Vitro</i> Pharmacokinetic Studies of a Dual Topoisomerase I/II Inhibitor.

Jonas Hildebrandt, Dirk O Bauerschlag, Gert Fricker

|Mar 13, 2025
Detection of Genomic Copy Number Variations in Ovarian Cancer in the Peripheral Blood System.

Lena Wahl, Ulyana Hliabtsova, Xueqian Qian

|Jun 27, 2024
Generation of a Specific Fluorescence In Situ Hybridization Test for the Detection of Ovarian Carcinoma Cells.

Amelie Limburg, Xueqian Qian, Bernice Brechtefeld

|Dec 23, 2023
Assessing the Phenotype of a Homologous Recombination Deficiency Using High Resolution Array-Based Comparative Genome Hybridization in Ovarian Cancer.

Svetlana Magadeeva, Xueqian Qian, Nadine Korff

|Dec 11, 2022
Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages.

Christoph Rogmans, Julia Feuerborn, Leonie Treeck

Pageof 2